Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
2021 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
Becker, M.; Strengert, M.; Junker, D.; Kaiser, P. D.; Kerrinnes, T.; Traenkle, B. & Dinter, H. et al. (2021)
Nature Communications, 12(1). DOI: https://doi.org/10.1038/s41467-021-20973-3
Documents & Media
Details
- Authors
- Becker, Matthias; Strengert, Monika; Junker, Daniel; Kaiser, Philipp D.; Kerrinnes, Tobias; Traenkle, Bjoern; Dinter, Heiko; Häring, Julia; Ghozzi, Stéphane; Zeck, Anne; Schneiderhan-Marra, Nicole
- Abstract
- Abstract The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed analysis is required to understand the manifestation and progression of COVID-19, monitor seroconversion within the general population, and support vaccine development. The majority of currently available commercial serological assays only quantify the SARS-CoV-2 antibody response against individual antigens, limiting our understanding of the immune response. To overcome this, we have developed a multiplex immunoassay (MultiCoV-Ab) including spike and nucleocapsid proteins of SARS-CoV-2 and the endemic human coronaviruses. Compared to three broadly used commercial in vitro diagnostic tests, our MultiCoV-Ab achieves a higher sensitivity and specificity when analyzing a well-characterized sample set of SARS-CoV-2 infected and uninfected individuals. We find a high response against endemic coronaviruses in our sample set, but no consistent cross-reactive IgG response patterns against SARS-CoV-2. Here we show a robust, high-content-enabled, antigen-saving multiplex assay suited to both monitoring vaccination studies and facilitating epidemiologic screenings for humoral immunity towards pandemic and endemic coronaviruses.
- Issue Date
- 2021
- Journal
- Nature Communications
- eISSN
- 2041-1723
- Language
- English
- Sponsor
- EC | Horizon 2020 Framework Programme https://doi.org/10.13039/100010661
Initiative and Networking Fund of the Helmholtz Association of German Research Centres - grant number SO-96